Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Omobonike Oloruntoba

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical Liver Disease|May 2, 2019
Integrating daclatasvir into hepatitis c therapyOmobonike Oloruntoba, Andrew J Muir
Clinical Liver Disease|June 26, 2023
Evaluation and management of post-transplant infections for the hepatologistOmobonike Oloruntoba-Sanders, Sajal D Tanna
Journal of Hospital Medicine|November 3, 2021
Clinical Progress Note: Intravenous Human Albumin in Patients With CirrhosisSuchita Shah Sata, Omobonike Oloruntoba Sanders, Catherine A Curley
Clinical Liver Disease|November 8, 2021
More Than Meets the Eye?Ying Claire Dorsey, Omobonike Oloruntoba, Avani A Pendse, et al.
Military Medicine|October 19, 2016
Implementation of Pharmacogenetic Testing Within the Veterans Health Administration From 2011 to 2013Julie Lynch, Scott L DuVall, Brygida Berse, et al.
European Radiology|November 27, 2020
Diagnosis of LI-RADS M lesions on gadoxetate-enhanced MRI: identifying cholangiocarcinoma-containing tumor with serum markers and imaging featuresHanyu Jiang, Bin Song, Yun Qin, et al.
Abdominal Radiology (New York)|April 28, 2025
Predictors of hepatocellular carcinoma in LR-M category lesions, a multi-institutional analysisMarybeth Nedrud, Tanya Wolfson, Brian Allen, et al.
Gastroenterology|August 3, 2019
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular CarcinomaAmit G Singal, Nicole E Rich, Neil Mehta, et al.
Gastroenterology|January 21, 2019
Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort StudyAmit G Singal, Nicole E Rich, Neil Mehta, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2019
Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular CarcinomaNicole E Rich, Ju Dong Yang, Ponni V Perumalswami, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical Liver Disease|May 2, 2019
Integrating daclatasvir into hepatitis c therapyOmobonike Oloruntoba, Andrew J Muir
Clinical Liver Disease|June 26, 2023
Evaluation and management of post-transplant infections for the hepatologistOmobonike Oloruntoba-Sanders, Sajal D Tanna
Journal of Hospital Medicine|November 3, 2021
Clinical Progress Note: Intravenous Human Albumin in Patients With CirrhosisSuchita Shah Sata, Omobonike Oloruntoba Sanders, Catherine A Curley
Clinical Liver Disease|November 8, 2021
More Than Meets the Eye?Ying Claire Dorsey, Omobonike Oloruntoba, Avani A Pendse, et al.
Military Medicine|October 19, 2016
Implementation of Pharmacogenetic Testing Within the Veterans Health Administration From 2011 to 2013Julie Lynch, Scott L DuVall, Brygida Berse, et al.
European Radiology|November 27, 2020
Diagnosis of LI-RADS M lesions on gadoxetate-enhanced MRI: identifying cholangiocarcinoma-containing tumor with serum markers and imaging featuresHanyu Jiang, Bin Song, Yun Qin, et al.
Abdominal Radiology (New York)|April 28, 2025
Predictors of hepatocellular carcinoma in LR-M category lesions, a multi-institutional analysisMarybeth Nedrud, Tanya Wolfson, Brian Allen, et al.
Gastroenterology|August 3, 2019
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular CarcinomaAmit G Singal, Nicole E Rich, Neil Mehta, et al.
Gastroenterology|January 21, 2019
Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort StudyAmit G Singal, Nicole E Rich, Neil Mehta, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2019
Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular CarcinomaNicole E Rich, Ju Dong Yang, Ponni V Perumalswami, et al.
Pageof 1